A.B.P. Nocivelli
On 26 March 2021, ABP Nocivelli S.p.A. obtained admission to negotiate ordinary shares on AIM Italia, a multilateral negotiations system organized and managed by Borsa Italiana. Negotiations began on 30 March 2021.
Integrae SIM acted as Nomad, Global Coordinator, and Issuer Specialist.
The total equivalent collected is equal to over 11 million euros resulting from the placement, at the price of 3.20 euros each, of a total of 3,450,000 ordinary shares, of which, at the start date of the negotiations, 3,050,000 newly issued and 400,000 shares placed within the fiscal year of the over-allotment option granted by the reference shareholder of the Company to Integrae Sim S.p.A.
The enterprise ABP Nocivelli specializes in the construction of technological systems and Facility Management services, a leader in the sector at a national level in most of the Public-Private Partnership operations for the construction of healthcare and hospital facilities.
Ultima Ricerca A.B.P. Nocivelli
UPDATE| Borgosesia reported results in line with the Business Plan, confirming a stable operating model and high profitability. Consolidated revenues amounted to €14.43 million, supported by real estate sales and income from repossession strategy receivables. Gross operating profit stood at €9.61 million, undergoing physiological normalization but still accounting for more than 50.0% of revenues, while EBITDA amounted to €7.29 million (margin of 52.5%) with net income of €2.08 million. On the strategic front, tangible progress has been made: the growth in AUM to €133.00 million (compared to €79.00 million at December 31, 2024) confirms the progress of the third-party management model, despite a natural phase of building fundraising capacity in a highly competitive market. Finally, disposals and collections during the period contributed to the improvement in Adj. NFP to €85.02 million, freeing up resources and strengthening the financial structure. Overall, the half-year shows concrete progress in the transformation process and lays a solid foundation for the expansion of recurring and asset-light activities. Considering the performance in the first half of the year and the Company’s recent announcements, we see no reason to update the forecasts made in the previous report. We expect FY25E production value to be €25.50 million with EBITDA of €12.50 million, corresponding to a margin of 49.0%, and growth in production value to €32.7 million (CAGR 24A-27E: 10.1%) in FY27E, with EBITDA of €19.00 million and a margin of 58.1%. We confirm our target price of €2.50, BUY rating, and MEDIUM risk. |
